a Division of General Internal Medicine, Department of Medicine , Weill Cornell Medical College , New York , NY , USA.
Expert Rev Anti Infect Ther. 2018 Dec;16(12):889-892. doi: 10.1080/14787210.2018.1547192. Epub 2018 Nov 14.
There remains significant controversy behind the Surviving Sepsis Campaign Guidelines, as evidenced by the Infectious Diseases Society of America refusing to endorse the latest iteration put forth by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine. An important stakeholder in this debate has not yet been adequately represented: hospitalists. Areas covered: In this perspective piece, we review the key points in this controversy; specifically, the current guidelines for the identification and management of sepsis. Expert commentary: We believe it is time for hospitalists to weigh in on this important issue by formally commenting on the new guidelines, establishing research priorities, and leading future research studies in the field to help achieve consensus among all clinicians in the appropriate management of sepsis.
在《拯救脓毒症运动指南》背后仍然存在着重大争议,这一点在美国传染病学会拒绝认可重症监护医学学会和欧洲危重病医学会提出的最新版本中得到了证明。这场争论中一个重要的利益相关者尚未得到充分代表:医院医生。涵盖领域:在这篇观点文章中,我们回顾了这场争论中的关键点;具体来说,就是目前脓毒症的识别和管理指南。专家评论:我们认为,现在是医院医生通过正式对新指南发表意见、确定研究重点以及领导该领域未来的研究工作来介入这一重要问题的时候了,这有助于所有临床医生在脓毒症的恰当管理方面达成共识。